SlideShare ist ein Scribd-Unternehmen logo
1 von 72
Virtual Potassium for the Intern
       (and other related electrolytes)



Intern Lecture Series
June 28th, 2011

Scott Pawlikowski, MD
Cardiology
Loyola University Medical Center / Hines VA
Goals of this Lecture
   SESSION OBJECTIVES
       Learn to effectively assess and manage
        hyperkalemia
       Learn to address various electrolyte deficiencies
        (low K+, low Mg2+, low phos, low Ca2+)
       Learn what serum electrolyte levels to follow in the
        hospital, and how often to follow them
       Apply your knowledge to real cases!
   LEARNING METHODS
       Lecture/material review
       Interactive case scenarios
            Real cases and real intern approaches to electrolyte
             disorders
What this lecture IS:
   A practical approach to handling
    electrolyte disorders in MOST
    hospitalized patients
   A guideline for supplementing
    electrolytes based on experiential
    and some evidence-based medical
    recommendations
   Hopefully an informative and useful
    tool
What this lecture IS NOT:
   A be-all, end-all list of all the causes
    of hyperkalemia, hypokalemia, etc.
   A thorough review of all the large
    center, prospective, randomized
    controlled trials on electrolyte
    replacement
       There really aren’t any!!!
   A complete reference that applies to
    every patient you will treat
Some Electrolyte Reference Ranges
          and Units (Hines VA)

   Potassium:      3.5   –   5.1 mEq/L
   Magnesium:      1.8   –   2.4 mg/dL
   Phosphorus:     2.5   –   4.5 mg/dL
   Calcium:        8.5   –   10.5 mg/dL
Hyperkalemia Overview
   Commonly encountered in
    hospitalized patients

   Most feared consequence:
       PEA
       Asystole

   Urgent vs. Emergent therapy?
       Stepwise approach
Approach to Hyperkalemia: Step 1
   Is it real?
       Assess for/exclude pseudohyperkalemia
          Hemolysis—ask RN/phlebotomist/lab tech
                 If suspected—order STAT repeat K+ level
            Potassium infusion—ask RN
                 If suspected—order STAT repeat K+ level from
                  peripheral vein AWAY from infusion site
            Check CBC (WBC > 70K, PLT > 1,000)
                 K+ moves out of WBC’s, PLT’s after clotting
                 If suspected—order STAT serum/plasma K+ levels
                      if serum K+ > plasma K+ by more than
                       0.3mEq/L, suspect pseudohyperkalemia

       In any case, have low threshold to repeat labs
Approach to Hyperkalemia: Step 2
   If real, why did it happen?
       Acute or chronic renal failure
       Medications (K+ sparing diuretics, ACE
        inhibitors, ARB’s, BB’s, digoxin, etc.)
       Endocrinopathies (hypoaldo, Addison’s)
       K+ supplements or salt substitutes
       K+ in IV infusions/TPN
Approach to Hyperkalemia: Step 3
   Is this an emergency?
       Did the K+ increase quickly?
          If yes, treat as emergency



       How high is the potassium level?
          If serum K+ ≥7.0 mEq/L, treat as emergency



       Any EKG changes of cardiac instability?
          If yes, treat as emergency

          Remember, the lack of EKG changes is NOT

           always entirely reassuring
Approach to Hyperkalemia: Step 3
   EKG assessment
       Four stages of EKG changes
          Peaked T waves
          PR prolongation/loss of P wave (unstable)

          QRS widening (unstable)

          Sine waves (very unstable)



       The “fifth” and final stage if
        hyperkalemia not addressed…
            PEA or asystole (i.e. cardiac arrest)
Approach to Hyperkalemia: Step 4
   Emergency therapy
       Part A: oppose toxic effects on cell membrane
          IV calcium infusion

                 Chloride: 3x the elemental calcium of gluconate
                 Gluconate: less toxic if IV extravasates
            Give 10mL ampule of 10% Calcium chloride
             vs. gluconate over 2-5 minutes
                 Too fast—pukey pukey!!!
                 Can repeat in 3-5 minutes if no EKG effect
            Keep EKG machine attached to patient!!!
                 EKG changes will diminish in 1-3 minutes
Approach to Hyperkalemia: Step 4
   Emergency therapy
       Part B: Shift K+ into cells
          Will buy you 1-4 hours before direct
           elimination methods “kick-in”
          Insulin/dextrose therapy
                 Regular insulin10 units IV push
                 50% Dextrose (“D50”) 1 ampule IV push
            Adjuncts (usually not necessary)
                 Albuterol nebulizer (continuous neb)
                 Sodium bicarbonate 1 ampule IV push
                     Only really helpful with coexistant acidosis

       Beware rebound hyperkalemia!!!
Approach to Hyperkalemia: Step 5
   Direct elimination of K+ from body
       Usually takes 4-6 hours to work
       Kayexalate (K+ binding resin/laxative combo)
          Give 30-60 gm

              PO if patient can tolerate

              PR (retention enema) if upper GI problems

              Patient needs to have a colon for this to work!

       Lasix?
          Works best when volume overloaded

       Hemodialysis (always discuss with renal fellow)
          Last resort or in severe cases
Approach to Hyperkalemia: Step 6
   Housekeeping/Follow Up
       Try to reverse/prevent/treat the cause
            Treatment of acute kidney injury
            Medication adjustment
       Monitor and reassess closely
            Should check serum K+ 4-8 hours after Rx initiated
            Beware of rebound hyperkalemia, especially if
             cellular shift Rx used!!
       ALWAYS discuss digitalis-toxicity associated
        hyperkalemia with your senior resident!!!
            Calcium infusion can potentiate the toxicity!!!
Hypokalemia Overview
   Occurs in over 20% of hospitalized patients

   Dangers
     Arrhythmia

     Rhabdomyolysis

     Paralysis



   Usually does NOT require emergency
    supplementation over minutes to hours
Approach to Hypokalemia: Step 1
   Redistribution or depletion?
       Redistribution causes (cellular shift)
          Insulin therapy (usually in DKA)
          Beta 2 agonists (e.g. albuterol)

          Metabolic alkalosis



       Replacing K+ in these settings may
        cause overshoot and hyperkalemia
Approach to Hypokalemia: Step 1
   Redistribution or depletion?
       Depletion causes (common)
          GI tract losses (diarrhea, vomiting)

          Loop/thiazide diuretic therapy

          Other medications (e.g. amphotericin B)

          Osmotic diuresis (DKA)

          Refeeding syndrome (NEVER underestimate!)

          Endocrinopathies (Conn’s syndrome, e.g.)

          Salt wasting nephropathies/RTA’s

          Magnesium deficiency (NEVER overlook!)
What is Refeeding Syndrome?
   Spectrum of electrolyte/volume disorders

   Occurs when previously malnourished patients are
    fed carbohydrate loads (PO or IV!)

   Triggered by intense insulin secretion

   Low phos/K+/Mg2+ (sometimes low blood sugar)

   Severe cases with unexplained CHF-like picture

   First identified/described in liberated POW’s,
    concentration camp survivors from WWII
Approach to Hypokalemia: Step 2
   Estimate the deficit
       For every 100 mEq below normal,
        serum K+ usually drops by 0.3 mEq/L
            Highly variable from patient to patient,
             however!!

       Dr. Popli’s estimation scheme
            For every 10 mEq below normal, serum
             K+ usually drops by 0.1 mEq
Approach to Hypokalemia: Step 3
   Choose route to replace K+
       In nearly all situations, ORAL
        replacement PREFERRED over IV
          Oral is quicker
          Oral has less side effects (IV burns!)

          Oral is less dangerous



       Choose IV therapy ONLY in patients
        who are NPO (for whatever reason) or
        who have severe depletion
Approach to Hypokalemia: Step 4
   Choose K+ preparation
       Oral therapy
            Potassium Chloride is PREFERRED AGENT
                 Especially useful in Cl-responsive metabolic
                  alkalosis
            Potassium Phosphate useful when
             coexistant phosphorus deficiency
                 Often useful in DKA patients
            Potassium bicarbonate, acetate,
             gluconate, or citrate useful in metabolic
             acidosis (“-ate” = bicarb former)
Approach to Hypokalemia: Step 4
   Choose K+ preparation
       IV therapy
          Adjunct to maintenance fluids (10-20 mEq/L)
                 “The surgical intern’s way”
                 Try to avoid using it!!!
                     you often forget it’s there

                     hyperkalemia can then develop, especially in

                      patients that get ARF in the hospital
            IV rider/”piggyback” (+/- lidocaine)
                 Generally 40-60 mEq
                 KCl is PREFERRED AGENT again
                     Can also use KPhos, Kbicarb, etc.

                 Avoid dextrose solution (trigger insulin, shift K+)
Approach to Hypokalemia: Step 5
   Choose dose/timing
       Mild/moderate hypokalemia
         3.0 to 3.5 mEq/L
         60-80 mEq PO (or IV) QDay divided doses

         Sometimes will require up to 160 mEq per

          day (refeeders, lots of diarrhea, IV
          diuretics)
         Avoid too much PO at once

                GI upset or just poor response
           Usually divide as BID or TID dosing
Approach to Hypokalemia: Step 5
   Choose dose/timing
       Severe hypokalemia (< 3.0 mEq/L)
         Can use combination of IV and PO, again
          with PO preferred if at all possible
         Avoid more than 60-80 mEq PO in a

          single dose
         Avoid IV infusion rates >20 mEq/hour

               Can cause arrhythmia!!!
               Most RN protocols won’t allow >10 mEq/hour
                rates on the floors (ICU’s too?)
Approach to Hypokalemia: Step 6
   Monitor/reassess
       Severe hypokalemia, DKA patients
            Reassess labs Q4-6 hours
       Moderate hypokalemia, IV diuresis
        patients
            Reassess labs BID to TID as needed
       Mild hypokalemia
            Reassess labs QDay or less as needed
Approach to Hypokalemia: Step 7
   Housekeeping/Follow Up
       BE AGGRESSIVE in DKA patients and IV
        diuresis patients
          “Moran’s Rule” for cardiac patients: keep
           K+ > 4.0 or even 4.5 mEQ/L
       BE GENTLE in patients with acute or chronic
        renal failure, and monitor very closely
          Cut dose in half
          Double dosing interval
          Do not replace at all


       NEVER forget to check for and treat
        hypomagnesemia in refractory hypokalemia!!!
Hypomagnesemia Overview
   Most of total body magnesium is intracellular
       Serum levels may NOT reflect intracellular status
       Low intracellular Mg2+ can occur in the setting of
        low, normal, and high serum magnesium levels
   Highest risk patients for hypomagnesemia
       Alcoholics
       Diabetics
       Critically ill patients
       Refeeding syndrome patients
   Rare symptoms (most patients asymptomatic)
       Neurologic
       Muscular
       Cardiac
Causes of Hypomagnesemia
   Poor PO intake and malabsorptive syndromes
   Alcohol ingestion (renal losses)
   Thiazide/loop diuretic administration
   Amphotericin administration
   Acute/chronic diarrhea
   DKA
   Refeeding syndrome
   Inadequate TPN dosing

   Diabetes mellitus? (at least an association)
Approach to Hypomagnesemia
   Unlike potassium replacement,
    magnesium replacement usually
    involves IV replacement
       All PO magnesium salts are all poorly
        absorbed
       High doses of PO magnesium usually
        leads to diarrhea
   Conversion rule: 8 mEq of
    magnesium sulfate equals 1 gram of
    magnesium sulfate (Hines CPRS)
Approach to Hypomagnesemia
   Rx in hospitalized patients
       1.6-2.0 mg/dL
           Give 2-4 gram IVPB (16-32 mEq)
                Usually infused at 1 gram/hour
       1.0-1.6 mg/dL
           Give 4-8 gram IVPB (32-64 mEq), usually
            in divided doses BID to TID
       <1.0 mg/dL
           Can give up to 8-12 gram IVPB (64-96
            mEq) in a single day, would divide into
            three-four doses
Approach to Hypomagnesemia
   Treating chronic low Mg2+ patients
       Give oral magnesium salt daily
            Sulfate, oxide, hydroxide, citrate, lactate,
             chloride, and gluconate available
            Gluconate less likely to cause diarrhea

       Periodic IM/IV dosing if/when needed

       My approach: Magnesium Oxide 420mg
        PO QDay to TID, based on level and
        tolerability
Approach to Hypomagnesemia
   Housekeeping/Follow Up
       BE AGGRESSIVE in DKA patients and IV
        diuresis patients
          “Moran’s Rule” for cardiac patients: keep
           Mg2+ > 2.0 or even 2.5 mEQ/L

       BE GENTLE in patients with acute or chronic
        renal failure, and monitor very closely
          Cut dose in half
          Double dosing interval
          Do not replace at all
Hypophosphatemia Overview
   Phosphorus is a critically important
    element in every cell
       Remember what the “P” stands for in
        ATP?
   Low phos commonly encountered in
    hospitalized patients
   Feared complication of severe
    deficiency is rhabdomyolysis
Causes of Hypophosphatemia
   Refeeding syndrome
   DKA
   Vitamin D deficiency
   Malabsorptive syndromes
   Alcoholism
   Inadequate TPN dosing
Approach to Hypophosphatemia
   Rx in hospitalized patients
       Mild to moderate hypophosphatemia
          1.5 -2.4 mg/dL
          Give phosphorus in the form of K+ or Na+
           salts PO BID to TID as needed
               Usually given as 1-2 packets of “neutraphos” BID
                to TID
       Severe deficiency
          <1.5 mg/dL
          Give IVPB in the form of sodium or
           potassium phosphate
               Usually given as 20-40 mEq/mmol rider infused
                over 2-4 hours
       Reasess labs QDay to TID as needed
Hypocalcemia Overview
   Hypocalcemia in hospitalized
    patients is usually spurious and/or
    DOES NOT need to be treated
   Aggressive management of
    hypocalcemia is usually ONLY
    indicated in “symptomatic” patients
       Active or latent tetany
       Cardiac dysrhythmia/prolonged QT
Hypocalcemia Overview
   Spurious hypocalcemia: low albumin
       Corrected Ca2+ = measured Ca2+ + [(normal
        albumin - measured serum albumin) x 0.8]
       Works well unless albumin < 2 mg/dL

   Hypocalcemia due to hyperphosphatemia
    from CKD/ESRD
       Aggressive calcium replacement is DANGEROUS
        —serum/tissue precipitation!!!
       Treat high phos and calcium level will improve
          Renal consults/senior resident can help with
           phosphate binder dosing/orders
Hypocalcemia Overview
   IV Calcium infusion can cause skin and
    muscle necrosis if it extravasates from IV
       May threaten limb or necessitate skin
        grafting!!!
   If replacement is needed, can usually give
    TUMS PO
   Severe depletion: discuss IV dosing with
    senior resident or endo consults
   Maintenance calcium replacement in TPN
    usually handled by nutrition support team
Recap of Major Learning Points
   Hyperkalemia
       Make sure it’s real
       Determine emergent or not
            Rate of rise, degree of hyperkalemia, EKG
       Treat emergent cases with calcium
        gluconate, insulin, dextrose, and
        kayexalate +/- dialysis/lasix
       Monitor closely for response to
        treatment—watch for rebound
       Fix the cause if possible
Recap of Major Learning Points
   Hypokalemia
       PO almost always preferred over IV
       KCl is preferred preparation
       Don’t give too much too quickly
       Be aggressive in DKA and IV diuresis
        patients
       Be gentle in renal failure patients
       Don’t forget to check magnesium levels
        in refractory patients
Recap of Major Learning Points
   Hypomagnesemia
       IV almost always preferred over PO
       Give IVPB in 2 gram increments
       Be aggressive in DKA patients, IV
        diuresis patients, and alcoholics
       Be gentle in renal failure patients
       PO does not work well and in high
        doses causes diarrhea
Recap of Major Learning Points
   Hypophosphatemia
       Can be treated with neutraphos packets PO
        BID/TID in mild cases
       Can be treated with sodium or potassium
        phosphate IVPB’s in severe cases
   Hypocalcemia
       Usually spurious or does not require Rx
       Avoid calcium replacement in CKD/ESRD
        patients with hyperphosphatemia
       Avoid IV calcium whenever possible
       Call for help if hypocalcemia really needs IV Rx
Getting Labs on Patients
   BMP
       QDay or Qother day on most hospitalized patients,
        especially if they have PO intake issues or are on
        maintenance fluids
   BMP with Mg levels
       QDay-BID on cardiology patients, alcoholics, and
        patients on amphotericin B
   BMP with Mg/Phos levels
       QDay-TID on tube feeding patients, DKA patients,
        or patients with suspected refeeding syndrome
   BMP with Ca/Mg/Phos levels
       QDay-4x/Day on TPN patients, AKI/CKD/ESRD
        patients, oncology patients (chemo/TLS),
        pancreatitis patients, critically ill patients
Ok, You Think You Got It???
   Let’s try it out on some cases
       3 Real cases from real patients at Hines

       Figure out what you would do...

       …then I’ll show you what the intern
        actually DID and what actually
        happened!
Case #1
   A 56 y/o male presents due to increased swelling
    in his face, legs, and abdomen, as well as
    increasing SOB and DOE. He is volume
    overloaded on exam. His labs are listed below.
    His serum albumin is 2.5 g/dL. Would you
    replace or treat anything?

Na+    K+    Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

133   5.5   101    18    51    9.5     83     8.2    2.1    6.0
Case #1 (continued)
   Patient’s EKG
Case #1 (continued)
   Here’s what the intern did…
       Gave 30gm Kayexalate PO
            Appropriate
       Gave lasix for volume overload, attempt at diuresis
        and potassium lowering
            Appropriate
       No insulin/dextrose/calcium gluconate
            Probably appropriate
       Gave phosphate binders for high phosphorus and
        DID NOT Rx low calcium (corrected calcium 9.4 mg/
        dL--normal)
            Very appropriate
       Discussed possible hemodialysis with senior
          Appropriate
Case #1 (continued)
   Here’s what the intern did…
       Rechecked K+ 12 hours later, still 5.5
        mEq/L
          Could have rechecked a little sooner

          Therfore gave another 30gm of

           Kayexalate PO
               Appropriate
       Rechecked K+ 8 hours later, down to
        5.1 mEq/L
Teaching Points
   Know the systematic approach to
    assessing and treating
    hyperkalemia
   Avoid unnecessary correction of low
    serum calcium values, especially
    when they are spuriously low
Case #2
   A 31 y/o male with a h/o severe HTN and
    resultant CKD and diastolic dysfunction/CHF
    presents with hypertensive urgency and CHF
    exacerbation. He is started on IV lasix and BP
    meds in the ED. His admission labs are below
    (taken prior to any medication administration).
    Would you replace or treat anything?

Na+     K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

137    3.5   100   26    25    2.8     125    9.1    1.9    3.5
Case #2 (continued)
   Here’s what the intern(s) did…
       No initial Rx for low normal K+ or Mg2+
        in the setting of CKD
            Probably appropriate, though could have
             given a little K+ PO (20 mEq) or Mg2+ IV
             (2 grams), given plans for IV lasix
       Repeated BMP and Mg2+ level in 12
        hours
            Appropriate
Case #2 (continued)
   The patient is responding to IV diuretics
    in terms of volume status and BP. His
    repeat labs are below (bottom row).
    What would you do now?

Na+    K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

137   3.5   100   26    25    2.8     125    9.1    1.9    3.5

139   5.4   106   29    23    2.4     102           1.9
Case #2 (continued)
   Patient’s EKG
Case #2 (continued)
   Here’s what the intern did…
       Did NOT bother to notice that hemolysis was
        noted on the lab report
           Ooops!

       Did NOT repeat BMP values before deciding
        treatment
           Ooops!

       Gave 15gm Kayexalate PO
           Big Ooops!

       Repeated BMP and Mg2+ level in 8 hours
           Appropriate, though intervention is suspect…
Case #2 (continued)
   The patient experienced 3-4 loose, watery
    BM’s and is now very frustrated. He is
    still receiving high dose IV diuretics. His
    repeat labs are listed below (bottom row).
     What would you do now?

Na+    K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

137   3.5   100   26    25    2.8     125    9.1    1.9    3.5

139   5.4   106   29    23    2.4     102           1.9

142   3.3   105   29    25    2.7     115           2.0
Case #2 (continued)
   Here’s what the intern(s) did…
       Gave 20mEq KCl PO and 20mEq KCl
        IVPB
            Most likely needed only PO potassium
             therapy, low dose probably appropriate,
             given CRI
       Repeated BMP and Mg2+ level in 12
        hours
            Probably appropriate
Case #2 (continued)
   The patient complains bitterly about the IV
    potassium infusion burning his arm. He’s still
    mad about the diarrhea from last night. He
    threatens to leave AMA and requires three
    separate MD conferences to keep him in the
    hospital! Repeat labs listed below (bottom row).

Na+     K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

137    3.5   100   26    25    2.8     125    9.1    1.9    3.5
139    5.4   106   29    23    2.4     102           1.9
142    3.3   105   29    25    2.7     115           2.0
139    3.6   102   29    24    2.6     96            2.1
Teaching Points
   Consider “staying ahead” of potassium
    and magnesium depletion in IV diuresis
    patients with replacement for low-normal
    values
   Suspect pseudohyperkalemia when things
    “just don’t add up”
   Be gentle in CKD patients
   PO potassium is PREFERRED over IV
    potassium in most situations
Case #3
   A 56 y/o male with a h/o chronic alcoholism and
    chronic dysphagia from prior CVA presents due to
    heavy drinking with nausea and vomiting at home.
    Patient is a poor historian and is VERY CACHECTIC on
    exam. He is placed on dextrose-containing IV fluids
    and made NPO. His labs are listed below. His serum
    albumin is 3.2 g/dL. Would you replace or treat
    anything?

Na+     K+    Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

140    4.7   99     29    11    1.1     89     9.6    1.3    3.4
Case #3 (continued)
   Here’s what the intern did…
       Gave thiamine and folate in addition to IVF as
        adjunctive therapy for chronic ETOHism
          Appropriate

       Did NOT supplement with any magnesium
        preparations
          Ooops!

       Repeated BMP, Mg2+ level, Phos level in 8
        hours
          Appropriate
Case #3 (continued)
   Patient continues to have dysphagia and
    nausea/vomiting problems. His repeat labs are
    listed below (bottom row)—these were drawn 36
    hours after admission (patient kept refusing labs).
     Service is planning on Dobhoff until full
    ENT/speech pathology workup complete. What
    would you do now?

Na+     K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos


140    4.7   99    29    11    1.1     89     9.6    1.3    3.4

136    3.9   100   23    5     0.9     46            1.3    2.4
Case #3 (continued)
   Here’s what the intern did…
       Gave 4gm magnesium sulfate IVPB
            Appropriate
       DID NOT further address the hypoglycemia
            Ooops!
       DID NOT supplement with any potassium or
        phosphorus
            Ooops!
       Repeated labs in 24 hours
            Probably should have repeated in 8-12 hours
       DID NOT ANTICIPATE this patient’s potential for
        continued electrolyte problems, given his alcoholism
        and high risk for refeeding syndrome
            Can happen even with IV dextrose infusion!!!
Case #3 (continued)
   Patient is getting more lethargic, starts to have
    fevers, service suspects aspiration pneumonia,
    eventually goes to MICU. He gets nutritional
    support off/on with Dobhoff, but keeps pulling it
    out. Here’s the next several days’ labs, with
    notes on replacement in-between

Na+     K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+    Phos

140    4.7   99    29    11    1.1     89     9.6    1.3     3.4

136    3.9   100   23    5     0.9     46            1.3     2.4

137    3.8   100   24    6     0.8     65            Oops!   Oops!
Case #3 (continued)
   Nothing gets replaced/addressed. New
    labs 12 hours later below (at bottom):




Na+    K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+    Phos

140   4.7   99    29    11    1.1     89     9.6    1.3     3.4
136   3.9   100   23    5     0.9     46            1.3     2.4
137   3.8   100   24    6     0.8     65            Oops!   Oops!

134   3.9   100   25                  65            1.3     4.1
Case #3 (continued)
   6gm magnesium sulfate IVPB given
   Labs redrawn 8 hours later, listed below
    (at bottom):

Na+    K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+    Phos

140   4.7   99    29    11    1.1     89     9.6    1.3     3.4
136   3.9   100   23    5     0.9     46            1.3     2.4
137   3.8   100   24    6     0.8     65            Oops!   Oops!

134   3.9   100   25                  65            1.3     4.1
137   3.8   103   24    9     1.0     80            2.4     3.6
Case #3 (continued)
   Finally making some progress!!! At this point
    tube feeds get started with some regularity. New
    labs drawn 24 hours later, listed below at bottom
    (line above is yesterday’s “perfect” labs). Serum
    albumin around this time is 2.1 g/dL.


Na+     K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos


137    3.8   103   24    9     1.0     80            2.4    3.6

138    3.4   106   26    8     0.9     129    7.9    1.3    2.7
Case #3 (continued)
   Nothing gets addressed/replaced by
    intern (Ouch, that hurts!)
   New labs 24 hours later, listed at bottom:


Na+    K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

137   3.8   103   24    9     1.0     80            2.4    3.6

138   3.4   106   26    8     0.9     129    7.9    1.3    2.7

141   2.9   105   28    4     0.8     124    7.7    0.9    2.9
Case #3 (continued)
   Finally, something starting to happen!!!
   Gets 20mEq KCL IVPB x 2 doses 4 hours apart
         Probably not enough, if you ask me…
   Gets 4gm magnesium sulfate IVPB
   Gets new labs in 12 hours this time (below, at
    bottom):

Na+        K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

137       3.8   103   24    9     1.0     80            2.4    3.6
138       3.4   106   26    8     0.9     129    7.9    1.3    2.7
141       2.9   105   28    4     0.8     124    7.7    0.9    2.9
138       3.6   106   27    3     0.8     89            1.6    Oops!
Case #3 (continued)
   Gets 4gm magnesium sulfate IVPB
   Gets new labs in 12 hours, listed below at
    bottom:

Na+    K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

137   3.8   103   24    9     1.0     80            2.4    3.6
138   3.4   106   26    8     0.9     129    7.9    1.3    2.7
141   2.9   105   28    4     0.8     124    7.7    0.9    2.9
138   3.6   106   27    3     0.8     89            1.6    Oops!

141   3.3   104   27    2     0.7     107           1.8    2.2
Case #3 (continued)
   Nothing supplemented (oh boy, here we
    go again…)
   New labs 12 hours later, at bottom:

Na+    K+   Cl-   CO2   BUN   Creat   Gluc   Ca2+   Mg2+   Phos

137   3.8   103   24    9     1.0     80            2.4    3.6
138   3.4   106   26    8     0.9     129    7.9    1.3    2.7
141   2.9   105   28    4     0.8     124    7.7    0.9    2.9
138   3.6   106   27    3     0.8     89            1.6    Oops!

141   3.3   104   27    2     0.7     107           1.8    2.2
140   3.1   105   28    2     0.9     100           1.2    2.3
Some Take Home Points
   Try to avoid “chasing your tail” on
    patients at high risk for continued
    electrolyte deficiencies
   Be aggressive in these patients, do not be
    afraid to replace lytes when at low-normal
    end of reference range
   Never underestimate the importance of
    maintainting electrolyte homeostasis, for
    the patient’s benefit and for YOUR benefit
       Your seniors and attendings will LOVE you!!!
References
Cody RJ, Pickworth KK: Approaches to diuretic therapy and
  electrolyte imbalance in congestive heart failure. Card Clin
  1994; 12: 37-50.

Kim G, Han J: Therapeutic approach to hypokalemia.
   Nephron 2002; 92(suppl 1): 28-32.

Kim H, Han S: Therapeutic approach to Hyperkalemia.
   Nephron 2002; 92(suppl 1); 33-40.

Whitmire SF: Fluid and electrolytes; in Gottschlich MM (ed):
  The Science and Practice of Nutrition Support; A Case-
  Based Core Curriculum. Dubuque, Kendall/Hunt, 2001, pp
  53-84.

Up to Date On-line

Weitere ähnliche Inhalte

Was ist angesagt?

Hypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatmentHypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatmentGarima Aggarwal
 
Potassium disorders , comprehensive & practical approach .
Potassium disorders , comprehensive & practical approach . Potassium disorders , comprehensive & practical approach .
Potassium disorders , comprehensive & practical approach . Yasser Matter
 
Hypokalemia & Hypomagnesemia
Hypokalemia & HypomagnesemiaHypokalemia & Hypomagnesemia
Hypokalemia & HypomagnesemiaSaurabh Tiwari
 
Electrolyte disorders in_critically_ill_patients__na
Electrolyte disorders in_critically_ill_patients__naElectrolyte disorders in_critically_ill_patients__na
Electrolyte disorders in_critically_ill_patients__naUbaidur Rahaman
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysisReynel Dan
 
Electrolyte imbalance
Electrolyte imbalanceElectrolyte imbalance
Electrolyte imbalanceTanoj Patidar
 
Disorder of sodium imbalance
Disorder of sodium imbalanceDisorder of sodium imbalance
Disorder of sodium imbalancePradip Katwal
 
Hyponatremia and hypernatremia
Hyponatremia and hypernatremiaHyponatremia and hypernatremia
Hyponatremia and hypernatremiaVineet Chowdhary
 
Sodium Bicarbonate Revisited
Sodium Bicarbonate RevisitedSodium Bicarbonate Revisited
Sodium Bicarbonate RevisitedCreativity Please
 
Potassium; Hypokalemia and hyperkalemia
Potassium; Hypokalemia and hyperkalemia Potassium; Hypokalemia and hyperkalemia
Potassium; Hypokalemia and hyperkalemia Joyce Mwatonoka
 
Hyperkalemia 160108171542
Hyperkalemia 160108171542Hyperkalemia 160108171542
Hyperkalemia 160108171542Indhu Reddy
 
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & ManagementDisorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & ManagementAbdullah Ansari
 
Hyponatremia gulidelines
Hyponatremia  gulidelinesHyponatremia  gulidelines
Hyponatremia gulidelinesViquas Saim
 
Hyperkalemia pathophysiology and treatment
Hyperkalemia pathophysiology and treatmentHyperkalemia pathophysiology and treatment
Hyperkalemia pathophysiology and treatmentDr Varun Patel
 

Was ist angesagt? (20)

Hypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatmentHypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatment
 
Potassium disorders , comprehensive & practical approach .
Potassium disorders , comprehensive & practical approach . Potassium disorders , comprehensive & practical approach .
Potassium disorders , comprehensive & practical approach .
 
Approach to Hypokalemia
Approach to HypokalemiaApproach to Hypokalemia
Approach to Hypokalemia
 
Hypokalemia & Hypomagnesemia
Hypokalemia & HypomagnesemiaHypokalemia & Hypomagnesemia
Hypokalemia & Hypomagnesemia
 
Electrolyte disorders in_critically_ill_patients__na
Electrolyte disorders in_critically_ill_patients__naElectrolyte disorders in_critically_ill_patients__na
Electrolyte disorders in_critically_ill_patients__na
 
Hypokalemia
Hypokalemia Hypokalemia
Hypokalemia
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
 
Electrolyte imbalance
Electrolyte imbalanceElectrolyte imbalance
Electrolyte imbalance
 
Disorder of sodium imbalance
Disorder of sodium imbalanceDisorder of sodium imbalance
Disorder of sodium imbalance
 
Hyponatremia and hypernatremia
Hyponatremia and hypernatremiaHyponatremia and hypernatremia
Hyponatremia and hypernatremia
 
CME - Hypokalemia
CME - HypokalemiaCME - Hypokalemia
CME - Hypokalemia
 
Sodium Bicarbonate Revisited
Sodium Bicarbonate RevisitedSodium Bicarbonate Revisited
Sodium Bicarbonate Revisited
 
Shock
ShockShock
Shock
 
Potassium; Hypokalemia and hyperkalemia
Potassium; Hypokalemia and hyperkalemia Potassium; Hypokalemia and hyperkalemia
Potassium; Hypokalemia and hyperkalemia
 
Hyperkalemia
HyperkalemiaHyperkalemia
Hyperkalemia
 
Hyperkalemia 160108171542
Hyperkalemia 160108171542Hyperkalemia 160108171542
Hyperkalemia 160108171542
 
Hypernatremia
HypernatremiaHypernatremia
Hypernatremia
 
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & ManagementDisorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
 
Hyponatremia gulidelines
Hyponatremia  gulidelinesHyponatremia  gulidelines
Hyponatremia gulidelines
 
Hyperkalemia pathophysiology and treatment
Hyperkalemia pathophysiology and treatmentHyperkalemia pathophysiology and treatment
Hyperkalemia pathophysiology and treatment
 

Ähnlich wie Hyperkalemia and other electrolytes disorders

Gopichand hypokalemia final
Gopichand hypokalemia finalGopichand hypokalemia final
Gopichand hypokalemia finalIndhu Reddy
 
potassiumimbalanceandmanagement-171224181212.pdf
potassiumimbalanceandmanagement-171224181212.pdfpotassiumimbalanceandmanagement-171224181212.pdf
potassiumimbalanceandmanagement-171224181212.pdfCutiePie71
 
Diabetic ketoacidosis ppt
Diabetic ketoacidosis pptDiabetic ketoacidosis ppt
Diabetic ketoacidosis pptPriyanka Karnik
 
Endocrineرائع emergencies
Endocrineرائع  emergenciesEndocrineرائع  emergencies
Endocrineرائع emergenciesWael Eladl
 
Hypokalemia and hyperkalemia indore pedicon 2014 final
Hypokalemia and hyperkalemia indore pedicon 2014 finalHypokalemia and hyperkalemia indore pedicon 2014 final
Hypokalemia and hyperkalemia indore pedicon 2014 finalRajesh Kulkarni
 
Dibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenDibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenCSN Vittal
 
Acute complications of diabetes mellitus
Acute complications of diabetes mellitusAcute complications of diabetes mellitus
Acute complications of diabetes mellitusikramdr01
 
Problems with Glucose KHMH 2023.pptx
Problems with Glucose KHMH 2023.pptxProblems with Glucose KHMH 2023.pptx
Problems with Glucose KHMH 2023.pptxrigomontejo
 
Hypokelemia and hyperkelemia
Hypokelemia and hyperkelemiaHypokelemia and hyperkelemia
Hypokelemia and hyperkelemiaCrazyMed
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in childrencharithwg
 
Management of Potassium Imbalance in Primary Care
Management of Potassium Imbalance in Primary CareManagement of Potassium Imbalance in Primary Care
Management of Potassium Imbalance in Primary Caredrmujahid2
 
Dka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentDka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentEyad Miskawi
 
Approch to a patient with acut comlications of dm
Approch to a patient  with acut comlications of dmApproch to a patient  with acut comlications of dm
Approch to a patient with acut comlications of dmsiifan23
 
TUMOR LYSIS SYNDROME
TUMOR LYSIS SYNDROMETUMOR LYSIS SYNDROME
TUMOR LYSIS SYNDROMEderosaMSKCC
 

Ähnlich wie Hyperkalemia and other electrolytes disorders (20)

Gopichand hypokalemia final
Gopichand hypokalemia finalGopichand hypokalemia final
Gopichand hypokalemia final
 
potassiumimbalanceandmanagement-171224181212.pdf
potassiumimbalanceandmanagement-171224181212.pdfpotassiumimbalanceandmanagement-171224181212.pdf
potassiumimbalanceandmanagement-171224181212.pdf
 
Diabetic ketoacidosis ppt
Diabetic ketoacidosis pptDiabetic ketoacidosis ppt
Diabetic ketoacidosis ppt
 
Endocrineرائع emergencies
Endocrineرائع  emergenciesEndocrineرائع  emergencies
Endocrineرائع emergencies
 
Hypokalemia and hyperkalemia indore pedicon 2014 final
Hypokalemia and hyperkalemia indore pedicon 2014 finalHypokalemia and hyperkalemia indore pedicon 2014 final
Hypokalemia and hyperkalemia indore pedicon 2014 final
 
Dibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenDibetic Ketoacidosis in Children
Dibetic Ketoacidosis in Children
 
Acute complications of diabetes mellitus
Acute complications of diabetes mellitusAcute complications of diabetes mellitus
Acute complications of diabetes mellitus
 
Hypokalemia
HypokalemiaHypokalemia
Hypokalemia
 
Hypokalemia.pptx
Hypokalemia.pptxHypokalemia.pptx
Hypokalemia.pptx
 
Problems with Glucose KHMH 2023.pptx
Problems with Glucose KHMH 2023.pptxProblems with Glucose KHMH 2023.pptx
Problems with Glucose KHMH 2023.pptx
 
Dka & hhs
Dka & hhsDka & hhs
Dka & hhs
 
Hypokelemia and hyperkelemia
Hypokelemia and hyperkelemiaHypokelemia and hyperkelemia
Hypokelemia and hyperkelemia
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in children
 
Management of Potassium Imbalance in Primary Care
Management of Potassium Imbalance in Primary CareManagement of Potassium Imbalance in Primary Care
Management of Potassium Imbalance in Primary Care
 
DKA.pptx
DKA.pptxDKA.pptx
DKA.pptx
 
Dka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentDka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managment
 
Approch to a patient with acut comlications of dm
Approch to a patient  with acut comlications of dmApproch to a patient  with acut comlications of dm
Approch to a patient with acut comlications of dm
 
DKA mgt protocol.pdf
DKA mgt protocol.pdfDKA mgt protocol.pdf
DKA mgt protocol.pdf
 
Diabetic ketoacidosis
Diabetic ketoacidosisDiabetic ketoacidosis
Diabetic ketoacidosis
 
TUMOR LYSIS SYNDROME
TUMOR LYSIS SYNDROMETUMOR LYSIS SYNDROME
TUMOR LYSIS SYNDROME
 

Mehr von Neurology Residency

Leptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPCLeptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPCNeurology Residency
 
Management of Increased intracranial pressure in cerebellar stroke
Management of Increased intracranial pressure in cerebellar strokeManagement of Increased intracranial pressure in cerebellar stroke
Management of Increased intracranial pressure in cerebellar strokeNeurology Residency
 
Progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathyProgressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathyNeurology Residency
 
Disorders of the neuromuscular junction
Disorders of the neuromuscular junctionDisorders of the neuromuscular junction
Disorders of the neuromuscular junctionNeurology Residency
 
Tetanus-strichnine toxicity & rabies
Tetanus-strichnine toxicity & rabiesTetanus-strichnine toxicity & rabies
Tetanus-strichnine toxicity & rabiesNeurology Residency
 
Somatosensory sistems and receptors
Somatosensory sistems and receptorsSomatosensory sistems and receptors
Somatosensory sistems and receptorsNeurology Residency
 
Taste and smell." Gustatory and Olfactory Pathways
Taste and smell." Gustatory and Olfactory PathwaysTaste and smell." Gustatory and Olfactory Pathways
Taste and smell." Gustatory and Olfactory PathwaysNeurology Residency
 

Mehr von Neurology Residency (20)

Leptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPCLeptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPC
 
Management of Increased intracranial pressure in cerebellar stroke
Management of Increased intracranial pressure in cerebellar strokeManagement of Increased intracranial pressure in cerebellar stroke
Management of Increased intracranial pressure in cerebellar stroke
 
Medication overuse headache
Medication overuse headacheMedication overuse headache
Medication overuse headache
 
Progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathyProgressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy
 
Disorders of the neuromuscular junction
Disorders of the neuromuscular junctionDisorders of the neuromuscular junction
Disorders of the neuromuscular junction
 
Pachymeningitis
PachymeningitisPachymeningitis
Pachymeningitis
 
Right AICA PICA stroke
Right AICA PICA strokeRight AICA PICA stroke
Right AICA PICA stroke
 
Tetanus-strichnine toxicity & rabies
Tetanus-strichnine toxicity & rabiesTetanus-strichnine toxicity & rabies
Tetanus-strichnine toxicity & rabies
 
Altered Mental Status
Altered Mental StatusAltered Mental Status
Altered Mental Status
 
Thalamic infarction
Thalamic infarctionThalamic infarction
Thalamic infarction
 
Somatosensory sistems and receptors
Somatosensory sistems and receptorsSomatosensory sistems and receptors
Somatosensory sistems and receptors
 
Neuromuscular junction
Neuromuscular junctionNeuromuscular junction
Neuromuscular junction
 
Acid Base Status
Acid Base StatusAcid Base Status
Acid Base Status
 
Cerebellum
CerebellumCerebellum
Cerebellum
 
Taste and smell." Gustatory and Olfactory Pathways
Taste and smell." Gustatory and Olfactory PathwaysTaste and smell." Gustatory and Olfactory Pathways
Taste and smell." Gustatory and Olfactory Pathways
 
Medulla
MedullaMedulla
Medulla
 
Lumbar plexus
Lumbar plexusLumbar plexus
Lumbar plexus
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 
Anatomy of basal ganglia
Anatomy of basal gangliaAnatomy of basal ganglia
Anatomy of basal ganglia
 
Anatomy of the pons
Anatomy of the ponsAnatomy of the pons
Anatomy of the pons
 

Kürzlich hochgeladen

Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 

Kürzlich hochgeladen (20)

Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 

Hyperkalemia and other electrolytes disorders

  • 1. Virtual Potassium for the Intern (and other related electrolytes) Intern Lecture Series June 28th, 2011 Scott Pawlikowski, MD Cardiology Loyola University Medical Center / Hines VA
  • 2. Goals of this Lecture  SESSION OBJECTIVES  Learn to effectively assess and manage hyperkalemia  Learn to address various electrolyte deficiencies (low K+, low Mg2+, low phos, low Ca2+)  Learn what serum electrolyte levels to follow in the hospital, and how often to follow them  Apply your knowledge to real cases!  LEARNING METHODS  Lecture/material review  Interactive case scenarios  Real cases and real intern approaches to electrolyte disorders
  • 3. What this lecture IS:  A practical approach to handling electrolyte disorders in MOST hospitalized patients  A guideline for supplementing electrolytes based on experiential and some evidence-based medical recommendations  Hopefully an informative and useful tool
  • 4. What this lecture IS NOT:  A be-all, end-all list of all the causes of hyperkalemia, hypokalemia, etc.  A thorough review of all the large center, prospective, randomized controlled trials on electrolyte replacement  There really aren’t any!!!  A complete reference that applies to every patient you will treat
  • 5. Some Electrolyte Reference Ranges and Units (Hines VA)  Potassium: 3.5 – 5.1 mEq/L  Magnesium: 1.8 – 2.4 mg/dL  Phosphorus: 2.5 – 4.5 mg/dL  Calcium: 8.5 – 10.5 mg/dL
  • 6. Hyperkalemia Overview  Commonly encountered in hospitalized patients  Most feared consequence:  PEA  Asystole  Urgent vs. Emergent therapy?  Stepwise approach
  • 7. Approach to Hyperkalemia: Step 1  Is it real?  Assess for/exclude pseudohyperkalemia  Hemolysis—ask RN/phlebotomist/lab tech  If suspected—order STAT repeat K+ level  Potassium infusion—ask RN  If suspected—order STAT repeat K+ level from peripheral vein AWAY from infusion site  Check CBC (WBC > 70K, PLT > 1,000)  K+ moves out of WBC’s, PLT’s after clotting  If suspected—order STAT serum/plasma K+ levels  if serum K+ > plasma K+ by more than 0.3mEq/L, suspect pseudohyperkalemia  In any case, have low threshold to repeat labs
  • 8. Approach to Hyperkalemia: Step 2  If real, why did it happen?  Acute or chronic renal failure  Medications (K+ sparing diuretics, ACE inhibitors, ARB’s, BB’s, digoxin, etc.)  Endocrinopathies (hypoaldo, Addison’s)  K+ supplements or salt substitutes  K+ in IV infusions/TPN
  • 9. Approach to Hyperkalemia: Step 3  Is this an emergency?  Did the K+ increase quickly?  If yes, treat as emergency  How high is the potassium level?  If serum K+ ≥7.0 mEq/L, treat as emergency  Any EKG changes of cardiac instability?  If yes, treat as emergency  Remember, the lack of EKG changes is NOT always entirely reassuring
  • 10. Approach to Hyperkalemia: Step 3  EKG assessment  Four stages of EKG changes  Peaked T waves  PR prolongation/loss of P wave (unstable)  QRS widening (unstable)  Sine waves (very unstable)  The “fifth” and final stage if hyperkalemia not addressed…  PEA or asystole (i.e. cardiac arrest)
  • 11. Approach to Hyperkalemia: Step 4  Emergency therapy  Part A: oppose toxic effects on cell membrane  IV calcium infusion  Chloride: 3x the elemental calcium of gluconate  Gluconate: less toxic if IV extravasates  Give 10mL ampule of 10% Calcium chloride vs. gluconate over 2-5 minutes  Too fast—pukey pukey!!!  Can repeat in 3-5 minutes if no EKG effect  Keep EKG machine attached to patient!!!  EKG changes will diminish in 1-3 minutes
  • 12. Approach to Hyperkalemia: Step 4  Emergency therapy  Part B: Shift K+ into cells  Will buy you 1-4 hours before direct elimination methods “kick-in”  Insulin/dextrose therapy  Regular insulin10 units IV push  50% Dextrose (“D50”) 1 ampule IV push  Adjuncts (usually not necessary)  Albuterol nebulizer (continuous neb)  Sodium bicarbonate 1 ampule IV push  Only really helpful with coexistant acidosis  Beware rebound hyperkalemia!!!
  • 13. Approach to Hyperkalemia: Step 5  Direct elimination of K+ from body  Usually takes 4-6 hours to work  Kayexalate (K+ binding resin/laxative combo)  Give 30-60 gm  PO if patient can tolerate  PR (retention enema) if upper GI problems  Patient needs to have a colon for this to work!  Lasix?  Works best when volume overloaded  Hemodialysis (always discuss with renal fellow)  Last resort or in severe cases
  • 14. Approach to Hyperkalemia: Step 6  Housekeeping/Follow Up  Try to reverse/prevent/treat the cause  Treatment of acute kidney injury  Medication adjustment  Monitor and reassess closely  Should check serum K+ 4-8 hours after Rx initiated  Beware of rebound hyperkalemia, especially if cellular shift Rx used!!  ALWAYS discuss digitalis-toxicity associated hyperkalemia with your senior resident!!!  Calcium infusion can potentiate the toxicity!!!
  • 15. Hypokalemia Overview  Occurs in over 20% of hospitalized patients  Dangers  Arrhythmia  Rhabdomyolysis  Paralysis  Usually does NOT require emergency supplementation over minutes to hours
  • 16. Approach to Hypokalemia: Step 1  Redistribution or depletion?  Redistribution causes (cellular shift)  Insulin therapy (usually in DKA)  Beta 2 agonists (e.g. albuterol)  Metabolic alkalosis  Replacing K+ in these settings may cause overshoot and hyperkalemia
  • 17. Approach to Hypokalemia: Step 1  Redistribution or depletion?  Depletion causes (common)  GI tract losses (diarrhea, vomiting)  Loop/thiazide diuretic therapy  Other medications (e.g. amphotericin B)  Osmotic diuresis (DKA)  Refeeding syndrome (NEVER underestimate!)  Endocrinopathies (Conn’s syndrome, e.g.)  Salt wasting nephropathies/RTA’s  Magnesium deficiency (NEVER overlook!)
  • 18. What is Refeeding Syndrome?  Spectrum of electrolyte/volume disorders  Occurs when previously malnourished patients are fed carbohydrate loads (PO or IV!)  Triggered by intense insulin secretion  Low phos/K+/Mg2+ (sometimes low blood sugar)  Severe cases with unexplained CHF-like picture  First identified/described in liberated POW’s, concentration camp survivors from WWII
  • 19. Approach to Hypokalemia: Step 2  Estimate the deficit  For every 100 mEq below normal, serum K+ usually drops by 0.3 mEq/L  Highly variable from patient to patient, however!!  Dr. Popli’s estimation scheme  For every 10 mEq below normal, serum K+ usually drops by 0.1 mEq
  • 20. Approach to Hypokalemia: Step 3  Choose route to replace K+  In nearly all situations, ORAL replacement PREFERRED over IV  Oral is quicker  Oral has less side effects (IV burns!)  Oral is less dangerous  Choose IV therapy ONLY in patients who are NPO (for whatever reason) or who have severe depletion
  • 21. Approach to Hypokalemia: Step 4  Choose K+ preparation  Oral therapy  Potassium Chloride is PREFERRED AGENT  Especially useful in Cl-responsive metabolic alkalosis  Potassium Phosphate useful when coexistant phosphorus deficiency  Often useful in DKA patients  Potassium bicarbonate, acetate, gluconate, or citrate useful in metabolic acidosis (“-ate” = bicarb former)
  • 22. Approach to Hypokalemia: Step 4  Choose K+ preparation  IV therapy  Adjunct to maintenance fluids (10-20 mEq/L)  “The surgical intern’s way”  Try to avoid using it!!!  you often forget it’s there  hyperkalemia can then develop, especially in patients that get ARF in the hospital  IV rider/”piggyback” (+/- lidocaine)  Generally 40-60 mEq  KCl is PREFERRED AGENT again  Can also use KPhos, Kbicarb, etc.  Avoid dextrose solution (trigger insulin, shift K+)
  • 23. Approach to Hypokalemia: Step 5  Choose dose/timing  Mild/moderate hypokalemia  3.0 to 3.5 mEq/L  60-80 mEq PO (or IV) QDay divided doses  Sometimes will require up to 160 mEq per day (refeeders, lots of diarrhea, IV diuretics)  Avoid too much PO at once  GI upset or just poor response  Usually divide as BID or TID dosing
  • 24. Approach to Hypokalemia: Step 5  Choose dose/timing  Severe hypokalemia (< 3.0 mEq/L)  Can use combination of IV and PO, again with PO preferred if at all possible  Avoid more than 60-80 mEq PO in a single dose  Avoid IV infusion rates >20 mEq/hour  Can cause arrhythmia!!!  Most RN protocols won’t allow >10 mEq/hour rates on the floors (ICU’s too?)
  • 25. Approach to Hypokalemia: Step 6  Monitor/reassess  Severe hypokalemia, DKA patients  Reassess labs Q4-6 hours  Moderate hypokalemia, IV diuresis patients  Reassess labs BID to TID as needed  Mild hypokalemia  Reassess labs QDay or less as needed
  • 26. Approach to Hypokalemia: Step 7  Housekeeping/Follow Up  BE AGGRESSIVE in DKA patients and IV diuresis patients  “Moran’s Rule” for cardiac patients: keep K+ > 4.0 or even 4.5 mEQ/L  BE GENTLE in patients with acute or chronic renal failure, and monitor very closely  Cut dose in half  Double dosing interval  Do not replace at all  NEVER forget to check for and treat hypomagnesemia in refractory hypokalemia!!!
  • 27. Hypomagnesemia Overview  Most of total body magnesium is intracellular  Serum levels may NOT reflect intracellular status  Low intracellular Mg2+ can occur in the setting of low, normal, and high serum magnesium levels  Highest risk patients for hypomagnesemia  Alcoholics  Diabetics  Critically ill patients  Refeeding syndrome patients  Rare symptoms (most patients asymptomatic)  Neurologic  Muscular  Cardiac
  • 28. Causes of Hypomagnesemia  Poor PO intake and malabsorptive syndromes  Alcohol ingestion (renal losses)  Thiazide/loop diuretic administration  Amphotericin administration  Acute/chronic diarrhea  DKA  Refeeding syndrome  Inadequate TPN dosing  Diabetes mellitus? (at least an association)
  • 29. Approach to Hypomagnesemia  Unlike potassium replacement, magnesium replacement usually involves IV replacement  All PO magnesium salts are all poorly absorbed  High doses of PO magnesium usually leads to diarrhea  Conversion rule: 8 mEq of magnesium sulfate equals 1 gram of magnesium sulfate (Hines CPRS)
  • 30. Approach to Hypomagnesemia  Rx in hospitalized patients  1.6-2.0 mg/dL  Give 2-4 gram IVPB (16-32 mEq)  Usually infused at 1 gram/hour  1.0-1.6 mg/dL  Give 4-8 gram IVPB (32-64 mEq), usually in divided doses BID to TID  <1.0 mg/dL  Can give up to 8-12 gram IVPB (64-96 mEq) in a single day, would divide into three-four doses
  • 31. Approach to Hypomagnesemia  Treating chronic low Mg2+ patients  Give oral magnesium salt daily  Sulfate, oxide, hydroxide, citrate, lactate, chloride, and gluconate available  Gluconate less likely to cause diarrhea  Periodic IM/IV dosing if/when needed  My approach: Magnesium Oxide 420mg PO QDay to TID, based on level and tolerability
  • 32. Approach to Hypomagnesemia  Housekeeping/Follow Up  BE AGGRESSIVE in DKA patients and IV diuresis patients  “Moran’s Rule” for cardiac patients: keep Mg2+ > 2.0 or even 2.5 mEQ/L  BE GENTLE in patients with acute or chronic renal failure, and monitor very closely  Cut dose in half  Double dosing interval  Do not replace at all
  • 33. Hypophosphatemia Overview  Phosphorus is a critically important element in every cell  Remember what the “P” stands for in ATP?  Low phos commonly encountered in hospitalized patients  Feared complication of severe deficiency is rhabdomyolysis
  • 34. Causes of Hypophosphatemia  Refeeding syndrome  DKA  Vitamin D deficiency  Malabsorptive syndromes  Alcoholism  Inadequate TPN dosing
  • 35. Approach to Hypophosphatemia  Rx in hospitalized patients  Mild to moderate hypophosphatemia  1.5 -2.4 mg/dL  Give phosphorus in the form of K+ or Na+ salts PO BID to TID as needed  Usually given as 1-2 packets of “neutraphos” BID to TID  Severe deficiency  <1.5 mg/dL  Give IVPB in the form of sodium or potassium phosphate  Usually given as 20-40 mEq/mmol rider infused over 2-4 hours  Reasess labs QDay to TID as needed
  • 36. Hypocalcemia Overview  Hypocalcemia in hospitalized patients is usually spurious and/or DOES NOT need to be treated  Aggressive management of hypocalcemia is usually ONLY indicated in “symptomatic” patients  Active or latent tetany  Cardiac dysrhythmia/prolonged QT
  • 37. Hypocalcemia Overview  Spurious hypocalcemia: low albumin  Corrected Ca2+ = measured Ca2+ + [(normal albumin - measured serum albumin) x 0.8]  Works well unless albumin < 2 mg/dL  Hypocalcemia due to hyperphosphatemia from CKD/ESRD  Aggressive calcium replacement is DANGEROUS —serum/tissue precipitation!!!  Treat high phos and calcium level will improve  Renal consults/senior resident can help with phosphate binder dosing/orders
  • 38. Hypocalcemia Overview  IV Calcium infusion can cause skin and muscle necrosis if it extravasates from IV  May threaten limb or necessitate skin grafting!!!  If replacement is needed, can usually give TUMS PO  Severe depletion: discuss IV dosing with senior resident or endo consults  Maintenance calcium replacement in TPN usually handled by nutrition support team
  • 39. Recap of Major Learning Points  Hyperkalemia  Make sure it’s real  Determine emergent or not  Rate of rise, degree of hyperkalemia, EKG  Treat emergent cases with calcium gluconate, insulin, dextrose, and kayexalate +/- dialysis/lasix  Monitor closely for response to treatment—watch for rebound  Fix the cause if possible
  • 40. Recap of Major Learning Points  Hypokalemia  PO almost always preferred over IV  KCl is preferred preparation  Don’t give too much too quickly  Be aggressive in DKA and IV diuresis patients  Be gentle in renal failure patients  Don’t forget to check magnesium levels in refractory patients
  • 41. Recap of Major Learning Points  Hypomagnesemia  IV almost always preferred over PO  Give IVPB in 2 gram increments  Be aggressive in DKA patients, IV diuresis patients, and alcoholics  Be gentle in renal failure patients  PO does not work well and in high doses causes diarrhea
  • 42. Recap of Major Learning Points  Hypophosphatemia  Can be treated with neutraphos packets PO BID/TID in mild cases  Can be treated with sodium or potassium phosphate IVPB’s in severe cases  Hypocalcemia  Usually spurious or does not require Rx  Avoid calcium replacement in CKD/ESRD patients with hyperphosphatemia  Avoid IV calcium whenever possible  Call for help if hypocalcemia really needs IV Rx
  • 43. Getting Labs on Patients  BMP  QDay or Qother day on most hospitalized patients, especially if they have PO intake issues or are on maintenance fluids  BMP with Mg levels  QDay-BID on cardiology patients, alcoholics, and patients on amphotericin B  BMP with Mg/Phos levels  QDay-TID on tube feeding patients, DKA patients, or patients with suspected refeeding syndrome  BMP with Ca/Mg/Phos levels  QDay-4x/Day on TPN patients, AKI/CKD/ESRD patients, oncology patients (chemo/TLS), pancreatitis patients, critically ill patients
  • 44. Ok, You Think You Got It???  Let’s try it out on some cases  3 Real cases from real patients at Hines  Figure out what you would do...  …then I’ll show you what the intern actually DID and what actually happened!
  • 45. Case #1  A 56 y/o male presents due to increased swelling in his face, legs, and abdomen, as well as increasing SOB and DOE. He is volume overloaded on exam. His labs are listed below. His serum albumin is 2.5 g/dL. Would you replace or treat anything? Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 133 5.5 101 18 51 9.5 83 8.2 2.1 6.0
  • 46. Case #1 (continued)  Patient’s EKG
  • 47. Case #1 (continued)  Here’s what the intern did…  Gave 30gm Kayexalate PO  Appropriate  Gave lasix for volume overload, attempt at diuresis and potassium lowering  Appropriate  No insulin/dextrose/calcium gluconate  Probably appropriate  Gave phosphate binders for high phosphorus and DID NOT Rx low calcium (corrected calcium 9.4 mg/ dL--normal)  Very appropriate  Discussed possible hemodialysis with senior  Appropriate
  • 48. Case #1 (continued)  Here’s what the intern did…  Rechecked K+ 12 hours later, still 5.5 mEq/L  Could have rechecked a little sooner  Therfore gave another 30gm of Kayexalate PO  Appropriate  Rechecked K+ 8 hours later, down to 5.1 mEq/L
  • 49. Teaching Points  Know the systematic approach to assessing and treating hyperkalemia  Avoid unnecessary correction of low serum calcium values, especially when they are spuriously low
  • 50. Case #2  A 31 y/o male with a h/o severe HTN and resultant CKD and diastolic dysfunction/CHF presents with hypertensive urgency and CHF exacerbation. He is started on IV lasix and BP meds in the ED. His admission labs are below (taken prior to any medication administration). Would you replace or treat anything? Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.5 100 26 25 2.8 125 9.1 1.9 3.5
  • 51. Case #2 (continued)  Here’s what the intern(s) did…  No initial Rx for low normal K+ or Mg2+ in the setting of CKD  Probably appropriate, though could have given a little K+ PO (20 mEq) or Mg2+ IV (2 grams), given plans for IV lasix  Repeated BMP and Mg2+ level in 12 hours  Appropriate
  • 52. Case #2 (continued)  The patient is responding to IV diuretics in terms of volume status and BP. His repeat labs are below (bottom row). What would you do now? Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.5 100 26 25 2.8 125 9.1 1.9 3.5 139 5.4 106 29 23 2.4 102 1.9
  • 53. Case #2 (continued)  Patient’s EKG
  • 54. Case #2 (continued)  Here’s what the intern did…  Did NOT bother to notice that hemolysis was noted on the lab report  Ooops!  Did NOT repeat BMP values before deciding treatment  Ooops!  Gave 15gm Kayexalate PO  Big Ooops!  Repeated BMP and Mg2+ level in 8 hours  Appropriate, though intervention is suspect…
  • 55. Case #2 (continued)  The patient experienced 3-4 loose, watery BM’s and is now very frustrated. He is still receiving high dose IV diuretics. His repeat labs are listed below (bottom row). What would you do now? Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.5 100 26 25 2.8 125 9.1 1.9 3.5 139 5.4 106 29 23 2.4 102 1.9 142 3.3 105 29 25 2.7 115 2.0
  • 56. Case #2 (continued)  Here’s what the intern(s) did…  Gave 20mEq KCl PO and 20mEq KCl IVPB  Most likely needed only PO potassium therapy, low dose probably appropriate, given CRI  Repeated BMP and Mg2+ level in 12 hours  Probably appropriate
  • 57. Case #2 (continued)  The patient complains bitterly about the IV potassium infusion burning his arm. He’s still mad about the diarrhea from last night. He threatens to leave AMA and requires three separate MD conferences to keep him in the hospital! Repeat labs listed below (bottom row). Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.5 100 26 25 2.8 125 9.1 1.9 3.5 139 5.4 106 29 23 2.4 102 1.9 142 3.3 105 29 25 2.7 115 2.0 139 3.6 102 29 24 2.6 96 2.1
  • 58. Teaching Points  Consider “staying ahead” of potassium and magnesium depletion in IV diuresis patients with replacement for low-normal values  Suspect pseudohyperkalemia when things “just don’t add up”  Be gentle in CKD patients  PO potassium is PREFERRED over IV potassium in most situations
  • 59. Case #3  A 56 y/o male with a h/o chronic alcoholism and chronic dysphagia from prior CVA presents due to heavy drinking with nausea and vomiting at home. Patient is a poor historian and is VERY CACHECTIC on exam. He is placed on dextrose-containing IV fluids and made NPO. His labs are listed below. His serum albumin is 3.2 g/dL. Would you replace or treat anything? Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 140 4.7 99 29 11 1.1 89 9.6 1.3 3.4
  • 60. Case #3 (continued)  Here’s what the intern did…  Gave thiamine and folate in addition to IVF as adjunctive therapy for chronic ETOHism  Appropriate  Did NOT supplement with any magnesium preparations  Ooops!  Repeated BMP, Mg2+ level, Phos level in 8 hours  Appropriate
  • 61. Case #3 (continued)  Patient continues to have dysphagia and nausea/vomiting problems. His repeat labs are listed below (bottom row)—these were drawn 36 hours after admission (patient kept refusing labs). Service is planning on Dobhoff until full ENT/speech pathology workup complete. What would you do now? Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 140 4.7 99 29 11 1.1 89 9.6 1.3 3.4 136 3.9 100 23 5 0.9 46 1.3 2.4
  • 62. Case #3 (continued)  Here’s what the intern did…  Gave 4gm magnesium sulfate IVPB  Appropriate  DID NOT further address the hypoglycemia  Ooops!  DID NOT supplement with any potassium or phosphorus  Ooops!  Repeated labs in 24 hours  Probably should have repeated in 8-12 hours  DID NOT ANTICIPATE this patient’s potential for continued electrolyte problems, given his alcoholism and high risk for refeeding syndrome  Can happen even with IV dextrose infusion!!!
  • 63. Case #3 (continued)  Patient is getting more lethargic, starts to have fevers, service suspects aspiration pneumonia, eventually goes to MICU. He gets nutritional support off/on with Dobhoff, but keeps pulling it out. Here’s the next several days’ labs, with notes on replacement in-between Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 140 4.7 99 29 11 1.1 89 9.6 1.3 3.4 136 3.9 100 23 5 0.9 46 1.3 2.4 137 3.8 100 24 6 0.8 65 Oops! Oops!
  • 64. Case #3 (continued)  Nothing gets replaced/addressed. New labs 12 hours later below (at bottom): Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 140 4.7 99 29 11 1.1 89 9.6 1.3 3.4 136 3.9 100 23 5 0.9 46 1.3 2.4 137 3.8 100 24 6 0.8 65 Oops! Oops! 134 3.9 100 25 65 1.3 4.1
  • 65. Case #3 (continued)  6gm magnesium sulfate IVPB given  Labs redrawn 8 hours later, listed below (at bottom): Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 140 4.7 99 29 11 1.1 89 9.6 1.3 3.4 136 3.9 100 23 5 0.9 46 1.3 2.4 137 3.8 100 24 6 0.8 65 Oops! Oops! 134 3.9 100 25 65 1.3 4.1 137 3.8 103 24 9 1.0 80 2.4 3.6
  • 66. Case #3 (continued)  Finally making some progress!!! At this point tube feeds get started with some regularity. New labs drawn 24 hours later, listed below at bottom (line above is yesterday’s “perfect” labs). Serum albumin around this time is 2.1 g/dL. Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.8 103 24 9 1.0 80 2.4 3.6 138 3.4 106 26 8 0.9 129 7.9 1.3 2.7
  • 67. Case #3 (continued)  Nothing gets addressed/replaced by intern (Ouch, that hurts!)  New labs 24 hours later, listed at bottom: Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.8 103 24 9 1.0 80 2.4 3.6 138 3.4 106 26 8 0.9 129 7.9 1.3 2.7 141 2.9 105 28 4 0.8 124 7.7 0.9 2.9
  • 68. Case #3 (continued)  Finally, something starting to happen!!!  Gets 20mEq KCL IVPB x 2 doses 4 hours apart  Probably not enough, if you ask me…  Gets 4gm magnesium sulfate IVPB  Gets new labs in 12 hours this time (below, at bottom): Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.8 103 24 9 1.0 80 2.4 3.6 138 3.4 106 26 8 0.9 129 7.9 1.3 2.7 141 2.9 105 28 4 0.8 124 7.7 0.9 2.9 138 3.6 106 27 3 0.8 89 1.6 Oops!
  • 69. Case #3 (continued)  Gets 4gm magnesium sulfate IVPB  Gets new labs in 12 hours, listed below at bottom: Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.8 103 24 9 1.0 80 2.4 3.6 138 3.4 106 26 8 0.9 129 7.9 1.3 2.7 141 2.9 105 28 4 0.8 124 7.7 0.9 2.9 138 3.6 106 27 3 0.8 89 1.6 Oops! 141 3.3 104 27 2 0.7 107 1.8 2.2
  • 70. Case #3 (continued)  Nothing supplemented (oh boy, here we go again…)  New labs 12 hours later, at bottom: Na+ K+ Cl- CO2 BUN Creat Gluc Ca2+ Mg2+ Phos 137 3.8 103 24 9 1.0 80 2.4 3.6 138 3.4 106 26 8 0.9 129 7.9 1.3 2.7 141 2.9 105 28 4 0.8 124 7.7 0.9 2.9 138 3.6 106 27 3 0.8 89 1.6 Oops! 141 3.3 104 27 2 0.7 107 1.8 2.2 140 3.1 105 28 2 0.9 100 1.2 2.3
  • 71. Some Take Home Points  Try to avoid “chasing your tail” on patients at high risk for continued electrolyte deficiencies  Be aggressive in these patients, do not be afraid to replace lytes when at low-normal end of reference range  Never underestimate the importance of maintainting electrolyte homeostasis, for the patient’s benefit and for YOUR benefit  Your seniors and attendings will LOVE you!!!
  • 72. References Cody RJ, Pickworth KK: Approaches to diuretic therapy and electrolyte imbalance in congestive heart failure. Card Clin 1994; 12: 37-50. Kim G, Han J: Therapeutic approach to hypokalemia. Nephron 2002; 92(suppl 1): 28-32. Kim H, Han S: Therapeutic approach to Hyperkalemia. Nephron 2002; 92(suppl 1); 33-40. Whitmire SF: Fluid and electrolytes; in Gottschlich MM (ed): The Science and Practice of Nutrition Support; A Case- Based Core Curriculum. Dubuque, Kendall/Hunt, 2001, pp 53-84. Up to Date On-line